Related Experiment Videos
The Italian hadrontherapy project CNAO.
1University of Milano Bicocca, Milan and TERA Foundation, Novara, Italy.
Summary
The TERA Foundation advances hadrontherapy research and development, focusing on ion beam therapy. Their main project, CNAO, utilizes an optimized medical synchrotron for advanced cancer treatment.
Area of Science:
- Medical physics and oncology
- Particle accelerator technology
- Radiation therapy research
Background:
- The Italian National Institute for Nuclear Physics (INFN) began hadrontherapy research in 1991.
- The TERA Foundation was established in 1992 to promote and construct hadrontherapy centers in Italy and Europe.
- Hadrontherapy, using ion beams, offers advanced cancer treatment possibilities.
Purpose of the Study:
- To review the current status of ion beam therapy.
- To describe the TERA Foundation's primary project, the National Center for Oncological Hadrontherapy (CNAO).
- To highlight the optimized medical synchrotron design developed within the Proton Ion Medical Machine Study (PIMMS).
Main Methods:
- Review of existing hadrontherapy research and clinical applications.
- Description of the PIMMS project (1996-1999) involving CERN, Med-AUSTRO, GSI, Oncology 2000, and TERA.
- Focus on the design of an optimized medical synchrotron for the CNAO facility.
Main Results:
- INFN's early involvement in hadrontherapy R&D.
- TERA Foundation's role in advancing hadrontherapy infrastructure.
- Development of an optimized medical synchrotron design through international collaboration.
Conclusions:
- The PIMMS project successfully designed an optimized medical synchrotron.
- The CNAO project, based on the PIMMS design, represents a significant advancement in hadrontherapy infrastructure.
- International collaboration is crucial for the development and implementation of advanced cancer treatment centers like CNAO.